Latest News
CenTrak Expands IoT Location and Sensing Services to Awarepoint Customers
Thursday 12 July 2018

12 July 2018 - US-based real-time location services provider CenTrak has transferred select assets of Awarepoint to its subsidiary Clinical Patents LLC (CPLLC), the company said.

The transfer of assets will further expand CenTrak's IoT Location and Sensing services with the addition of Bluetooth Low Energy sensor technology.

This transfer includes over twenty patents, many which are focused on mobile device locating and enhancing the accuracy and performance of traditional BLE systems.

For existing Awarepoint customers, resources are in place to offer service and support. Awarepoint engineering and technical support personnel have been hired by CPLLC to ensure continuity of support.

Awarepoint technology has been installed in hundreds of prominent hospitals and clinics throughout North America, leveraging hundreds of thousands of IoT sensors and tags.

CenTrak now has access to key technology features, including mobile device locating to supplement CenTrak's Connect platform, where it can be synthesized with the other technologies CenTrak already supports, including: Wi-Fi, Second Generation Infrared (Gen2IR), UHF Active RFID, Low Frequency, Passive RFID, BLE and Advanced Ultrasound.

The combination of these technologies will further expand the breadth of use cases which can be addressed using healthcare's provider of Enterprise-class Location and Sensing Services.

CenTrak improves healthcare operational efficiency and the quality of patient care via a scalable Enterprise Location Services offering.
Date Published: 12/07/2018
Target: Awarepoint/certain assets, including over twenty patents
Country: USA
Sector: Healthcare
Type: Corporate acquisition
Status: Closed
Vendor: Awarepoint
Buyer: CenTrak
Terms of the deal were not disclosed